Published Date: 02 Mar 2023
Researchers from the University of Queensland have confirmed that genes associated with the risk of Parkinson's disease also contribute to the production of cellular debris in the brain.
Read Full NewsA new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and increased survival rates, many patients worldwide are not receiving the compassionate, holistic support ...
Glioblastoma is one of the most aggressive and complex brain cancers. It grows quickly, resists standard treatments, and often leaves patients and their families searching for every possible option.
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of overdiagnosis, or the detection ...
1.
In a study, immune detection of oral cancers is linked to obesity.
2.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
3.
Q&A: How early cancer screening could save Canada nearly half a billion dollars over patients' lifetimes
4.
iPSC-based vaccines: A new hope for preventing and treating colorectal cancer
5.
Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.
1.
Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends
2.
What Is A High MCV Level? Causes, Symptoms, And Treatment Options
3.
Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection?
4.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
5.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
2.
Navigating the Complexities of Ph Negative ALL - Part III
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
4.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
5.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation